Delivering measurable outcomes through precision, expertise and next-generation technology.
Since our establishment in 2018, we at Blockchain AI Solutions, we believe that true operational excellence requires more than just strategic advice or standalone software, it requires the seamless integration of both. We are a pioneering consultancy and technology firm dedicated to transforming infrastructure, supply chain, food and pharmaceutical organizations as well as bespoke software solutions. We bring together two of the most innovative technologies, blockchain and AI to provide the most cutting edge solutions to our clients, particularly those that are subject to strict regulation.
Founded on the principle that regulatory compliance should be a strategic advantage rather than a burden, we bridge the gap between expert consulting and innovative technology implementation. Our approach delivers comprehensive strategies grounded in deep industry experience and full digitization across whole organizations.
We do not just make recommendations, we build the digital infrastructure required to sustain them. By leveraging the latest advances in blockchain, artificial intelligence, and cloud technology, we provide our clients with secure, scalable foundations that ensure data integrity, eliminate silos, and automate complex compliance requirements.
Our Mission: To empower global organizations through integrated consulting and cutting-edge technological innovation.
Our Vision: To be the global standard for operational excellence, where every supply chain is transparent, every process is optimized, and every regulatory requirement is met with automated precision.
Raja Sharif is the Founder and CEO of FarmaTrust. He is driving the company’s vision and mission of protecting the vulnerable by eliminating deadly counterfeit medications on a global scale. Raja has managed a number of technology and media projects worldwide for some of the best known brands, including British Telecom and Al Jazeera. He is a Barrister by background, having worked as General Counsel and company secretary managing legal affairs, risk and good corporate governance.
Mike Quin has been involved in IT since 1979 having started as a graduate trainee with Burroughs Machines; the number two global IT business at that time. Over the years he has held director level roles at the likes of AIM Limited a legal systems house, Guardian iT a disaster recovery provider which following an MBI went onto a successful full listing on the LSE, The Bladder and Bowel Community who provide an information service to their 3 million online visitors per annum, FarmaTrust the leading track and trace & clinical trial data solution provider to the health sector.
Fahad has more than 20 years of international technical experience, in USA, UK, and Middle East which includes Application Design and Development. Experienced in developing the Enterprise, Digital, Media and blockchain products. He has significant experience of large company technical needs, is responsible for the technical infrastructure and also system architecture. Was responsible for first prototype of the blockchain layer.
Monika is an experienced marketing manager and has worked alongside industry professionals in a wide variety of fields. Her work spans all touchpoints from websites to social media, and advertising to live events. She also works with our PR and technical departments to ensure that we have great market exposure in respect of our new products and our pipeline.
David has over 17 years of experience in Pharmaceutical & Medical Device manufacturing, specializing in complex Manufacturing IT projects – with Manufacturing Execution Systems (MES) and Serialization being a key focus. David is passionate about patient safety and has driven successful business transformational projects for major pharmaceutical companies globally.
Arnab is one of the leading advocates and member of Global Blockchain healthcare community, He is committed to driving strategy for the success of Blockchain technology & Home health best use cases. He was elected member of Beta Kappa Chi (National Scientific honor Society, USA). Actively involved in the Blockchain Task Force, HIMSS, USA. He also serves as a Advisory Board Member of IoT Health slam, NY, USA. He has consulted with Healthcare and medical device clients internationally on market readiness, innovative data analytics, and consumer engagement solutions. Arnab is a valuable asset to the team in his role as Strategic Advisor. Arnab is looking to ensure the Pharmaceutical and the Healthcare sector deliver effective improvements in patient care and realise substantial supply chain efficiencies by implementing our solutions.
Prof Mimoun Azzouz, formerly Director of Neurobiology at Oxford BioMedica, is Professor of Translational Neuroscience and Director of the Gene Therapy Innovation & Manufacturing Centre (GTIMC) at the University of Sheffield. His pioneering research has delivered major breakthroughs in gene therapy, with real-world impact across neurodegenerative diseases. His team led landmark work demonstrating the success of SMN gene therapy in spinal muscular atrophy, helping pave the way for licensed treatments. He has also driven pre-clinical work leading to first-in-human trials in Parkinson’s disease, advanced gene therapy approaches for ALS, and developed therapies now entering clinical trials for HSP47. Beyond research, Professor Azzouz established the GTIMC to boost UK capacity for clinical vector manufacturing and co-led the €25.5M ARDAT consortium with Roche to accelerate advanced therapy development across multiple disease areas. A scientific founder and entrepreneur, he continues to shape the future of ATMPs through innovation, training and collaboration across academia and industry. Azzouz is a co-founder of BlackfinBio and Crucible Therapeutics.
Ronald Kompier has 35 years of experience in the vaccine field, i.e. leading positions in the Research, Development, Manufacturing, Quality Control, Quality Assurance, Regulatory Affairs and Clinical Development of human and veterinary vaccines. Specifically, in the pharmaceutical industry Ronald has managed Quality Control laboratories (>50 FTE) and has been responsible for liaising with multiple National Control Laboratories for multiple vaccines. For almost 20 years Ronald has been a member of the IFPMA, for 15 years Ronald has been a consultant at Vaccine Consultancy (performing GMP audits all over the world), for 10 years he has been the Managing Director of the Biotech Training Facility (training employees of the SFDA).
Dr. Gaurav Gupta is a biotechnology expert with over 20 years of global experience in vaccine and biotherapeutic development, specializing in CMC, GMP manufacturing, and end-to-end R&D across multiple platforms — including viral-vectored, mRNA, live viral, inactivated and protein-based vaccines. He currently serves as Director and Lead Consultant at Vaxbiosolutions, while also holding roles as Head of Research at Granza Bio (UK) and CMC Manager at Loma Therapeutics (Denmark). Dr. Gupta has played key roles in the development of the Oxford-AstraZeneca COVID-19 vaccine and has led programs at Speransa Therapeutics, VMIC, Jenner Institute, Zydus Cadila, and others globally. He has delivered 11 products from concept to market and led 50 plus human clinical trials manufacturing for vaccines. He is Phd in Virology and immunology.
Dr Vaughan Thomas has over 35 years’ experience in the biopharmaceutical sector. His knowledge covers all aspects of the biopharma industry, covering laboratories and process facilities. As well as leading process design teams on major capital manufacturing projects, Vaughan has expertise in laboratory design, capacity analysis, contractor selection, operational improvements and scale-up of processes. Since 2016, he has been a Visiting Professor in the Department of Biochemical Engineering at UCL where he teaches on the Design Project and has assisted in the development of new courses in the Regenerative Medicine field. During the COVID-19 pandemic, he worked as a Technical Advisor for the Vaccines Taskforce.
Professor Chris Elliott (OBE) PhD is a leading expert on international food supply chains and the implications for food quality, authenticity, integrity and safety. Founder of the Institute for Global Food Security at Queen’s, Professor Elliott’s main research interests are in the development of innovative techniques to provide early warning of toxin threats across complex food supply systems. He has published more than 350 papers in the field of detection and control of chemical contaminants in agri-food commodities, as well as leading a range of international projects in developing safer food supply systems. Professor Elliott led the independent review of Britain’s food system following the 2013 horsemeat scandal. He was awarded an OBE in 2017 for services to the agri-food supply chain.
John Points is an expert in Veterinary Residues Analysis: He has extensive experience and knowledge in the field of analyzing veterinary medicine residues. John was appointed to the veterinary residues committee in 2011 and has participated in industry discussions, for example, co-hosting a podcast on World Antimicrobial Awareness Week in 2022.
Dr. Octavian Mihalache (Food Science and Engineering) is currently working as a Marie-Curie Postdoctoral Fellow at the Department of Food and Drug, University of Parma, Parma Italy. His research topics mainly include chemical risk assessment, risk–benefit assessment, dietary exposure, food safety, food hygiene, qualitative data analysis, and quantitative data analysis. Dt. Octavian has 29 publications to his name.
Dr. Martin Danahar, Adjunct Professor TU Dublin, Principal Research Officer at Teagasc. Dr Danaher has developed state-of-the-art testing programmes in Ireland for antiparasitic drugs and nitrofurans residues, which were accredited to ISO17025 standards. Dr Danaher has published 118 peer reviewed papers and six book chapters.
Dr. Rosa Busquets, is an expert in analytical and materials science and cover development of analytical methods, environmental monitoring and remediation to increase access of safe drinking water and improve the environment. She is member and author of the UNEP Environmental Effects Assessment Panel (EEAP). EEAP informs the Parties to the Montreal Protocol on matters arising from ozone depletion, UV radiation and the interaction of climate change. Dr. Rosa contributes to the Royal Society of Chemistry Science Policy Panel Engagement group feeding views from the scientific community on Chemicals, Waste and Reduction of Pollution to the UN. Dr. Rosa has authored 2 books and has produced a significant number of articles.
Dr. Kaushik Banerjee, Honorary Professor, FRSC, FRNNS specialises in agricultural and food safety, an expert in developing rapid testing methods for food contamination. He is a Fellow of the Indian National Academy of Agricultural Sciences (FNAAS) and the Royal Society of Chemistry (FRSC). He is also the current Chairman and a Past President of the India section of AOAC INTERNATIONAL. Dr. Kaushik has 220 publications to his name.
Dr. Andrew Cannavan, FIFST, Honorary Professor is an expert in food chemistry, food processing and engineering, high-performance liquid chromatography, food quality, food analysis. Dr Andrew Cannavan led the International Atomic Energy Agency’s Food Safety Assessment Team in Fukushima after the nuclear disaster and works closely with the Queen’s University Institute for Global Food Security. Dr. Andrew has 140 publications.
Dr. Di Wu has been working within a series of international collaboration frameworks in food authenticity and food safety. His current research interests focus on developing fingerprinting tools for geographic origins and potential fraud issues related. He is also involved in development of an emerging nanopore system for in vitro single molecule function studies of DNA and proteins. His expertise includes identification of risks for alternative protein and its testing methods (targeting DNA, peptide and chemical contaminants).
Dr Paul N. Williams is a fellow of the Institute for Global Food Security, Director of QUB’s Agricultural Technology Degree, and Senior Lecturer in Soil & Environmental Biogeochemistry. Paul’s research interests centre on environmental/elemental metrology, understanding plant-soil interactions and improved soil management. Paul has written over 70 papers.
Dr Manus Carey is a Research Fellow at the Institute for Global Food Security, School of Biological Sciences, Queen’s University Belfast. Skills and Expertise: Elemental Analysis, Mass Spectrometry, Spectrometry, Sample Preparation, Environmental Analytical Chemistry, Analytical Chemistry Instrumentation, Analytical Method Development, Chemical Analysis and Analytical Instruments. Paul has written 85 publications.
Dr Hans-Joachim Hübschmann, graduated as Certified Food Chemist from the Technical University in Berlin, Germany. In 2002 he joined Thermo Fisher Scientific in Bremen, Germany, and held different international positions in inorganic and isotope ratio mass spectrometry and high-resolution GC-MS and GC-MS/MS. In 2015 he established the independent consulting agency HANS Analytical Solutions. In his current capacity Hans-Joachim is serving private and industrial laboratories and international analytical instrument companies for green and automated methods development as well as training. He has authored 3 books including the popular Handbook of GC-MS by Hans-Joachim Hübschmann which is now in its 4th edition.
Professor Damià Barceló is a renowned environmental chemist and a leading expert on emerging contaminants, microplastics, and water quality, with an extensive publication record and high international citation metrics. He holds several academic positions, including Honorary Adjunct Professor at the University of Almeria and retired Full Research Professor at IDAEA-CSIC, and has also served as the Director of the Catalan Institute for Water Research (ICRA). He is recognized globally for his work in developing analytical methods, understanding the environmental fate of pollutants, and his significant contributions to environmental science and sustainable water management.
Dr Nicholas Birse currently works as a Lecturer at the School of Biological Sciences, Queen’s University Belfast. Nicholas does research in Molecular Biology, Analytical Chemistry and Medicinal Chemistry. He is skilled in the development of mass spectrometry and liquid chromatography methods, and in the operation and maintenance of instrumentation from multiple vendors. He has 21 publications to his name.
Sufyan Pandor is currently an Automation Product Specialist at Agilent Technologies. Sufyan Pandor brings experience from previous roles at Agilent Technologies and Thornton & Ross. Sufyan Pandor holds a 2019 – 2021 Doctor of Philosophy – PhD in Food Security @ Queen’s University Belfast. With a robust skill set that includes Validation, Quality Systems, Analytical Chemistry, HPLC, GMP and more.
Saad Al Dawood is the Vice Dean for Graduate Studies and Scientific Research, at King Saud University. He is Specialized in: – Detector Technology – Image processing – Radiotherapy – Nuclear medicine. He has 67 research works with 725 citations
Saad Al Dawood is the Vice Dean for Graduate Studies and Scientific Research, at King Saud University. He is Specialized in: – Detector Technology – Image processing – Radiotherapy – Nuclear medicine. He has 67 research works with 725 citations
We combine deep domain expertise in compliance, blockchain infrastructure and AI automation to help organisations transform complexity into competitive advantage.
Immutable, transparent ledger solutions tailored to your industry's compliance requirements and scale.
Intelligent process automation that reduces manual overhead, accelerates audits and flags anomalies in real time.
Expert guidance on navigating complex frameworks across pharmaceuticals, finance and global supply chains.
Dashboards and alert systems that give stakeholders instant visibility into compliance status and supply chain health.
A multidisciplinary team of professors, engineers and compliance specialists with decades of combined experience.
Custom-built platforms that integrate with your existing systems, delivering exactly what you need — nothing more, nothing less.
Our sprint-based delivery model means you see working software fast — not after months of consultancy. We embed alongside your team, align on outcomes and iterate rapidly.